Table 12 definition

Table 12. Analysis 2c: metric selection results. Metric - stressor correlation was consistent (yes) if the sign of the correlation was as expected. Xxxxxxxx rank correlation between the EQR, calculated using the formula EQR1, and the stressor is reported. A metric was redundant (redundancy=yes) if correlated (r>0.8)
Table 12. Key state funding programs and amounts for Chesapeake Bay Restoration Projects. Program(s) Name State’s 2019 Program Funding Levels Bay Restoration Fund Wastewater & Water Quality Revolving Loan Fund $306-million/yr* Bay Restoration Fund Septic $15-million/yr Clean Water Commerce Act $6-million/yr Chesapeake and Atlantic Coastal Bays Trust Fund $53-million/yr Maryland Agricultural Cost Share $9-million/yr Total $389-million/yr *Includes $150-million in revenue bonds. Successive years anticipated to be $22-million In addition to traditional funding approaches, the Xxxxx administration is pursuing market-based strategies designed to stimulate a restoration economy and reduce costs. Nutrient trading is one such tool that allows non-mandated pollution reductions from one entity to be purchased by another entity. This creates a marketplace that will drive innovation across sectors to develop the most cost effective pollution reduction practices. At the same time, other innovative financing strategies like the Clean Water Commerce Act and the CWIP drive innovation by creating funding streams for the most cost effective practices and developing collaborative funding models like public-private partnerships to reduce public costs of restoration. Aligning Maryland’s GHG reduction actions with Bay restoration actions that have significant carbon sequestration benefits can leverage and diversify financing to accelerate pollution reduction practices. Maryland is also actively pursuing water reuse technologies that help with long term water supply sustainability for our citizens, as well as reduce pollution loads to Chesapeake Bay20.
Table 12. Drug names and routes of administration that are mentioned in documents. Drug Dosage Form #docs Drug Dosage Form #docs TALC POWDER 570 ESTRADIOL TABLET 78 SODIUM CHLORIDE INJECTABLE 429 IBUPROFEN TABLET 77 DIMETHYL SULFOXIDE SOLUTION 276 IFOSFAMIDE INJECTABLE 76 INSULIN INJECTABLE 265 INDOMETHACIN CAPSULE 75 FLUOROURACIL SOLUTION 256 AMPICILLIN CAPSULE 72 DEXAMETHASONE SOLUTION 247 BALANCED SALT SOLUTION 71 LENTE INJECTABLE 242 PREDNISONE TABLET 70 STERILE WATER LIQUID 229 ISOFLURANE LIQUID 70 SODIUM BICARBONATE INJECTABLE 183 POTASSIUM IODIDE SOLUTION 70 CYCLOSPORINE SOLUTION 181 MEGESTROL ACETATE SUSPENSION 66 PREDNISONE SOLUTION 176 THIOTEPA INJECTABLE 65 FLUOROURACIL INJECTABLE 153 SIMVASTATIN TABLET 65 IBUPROFEN SUSPENSION 150 LOVASTATIN TABLET 64 CISPLATIN INJECTABLE 149 MERCAPTOPURINE TABLET 62 DEXAMETHASONE INJECTABLE 147 HYDROCORTISONE POWDER 62 CYCLOPHOSPHAMIDE INJECTABLE 140 TAXOTERE INJECTABLE 61 MAGNESIUM SULFATE INJECTABLE 133 DIAZEPAM SOLUTION 60 ETOPOSIDE INJECTABLE 133 DACARBAZINE INJECTABLE 59 AMMONIUM CHLORIDE INJECTABLE 127 FLUOROURACIL CREAM 58 PACLITAXEL INJECTABLE 126 TESTOSTERONE INJECTABLE 57 INDOMETHACIN SUSPENSION 118 THEOPHYLLINE SOLUTION 56 TAXOL INJECTABLE 113 FUROSEMIDE SOLUTION 56 ADENOSINE INJECTABLE 112 FLUTAMIDE CAPSULE 55 MITOMYCIN INJECTABLE 109 HYDROCHLOROTHIAZIDE SOLUTION 55 CYCLOPHOSPHAMIDE TABLET 107 POTASSIUM CHLORIDE INJECTABLE 55 CARBOPLATIN INJECTABLE 102 PREDNISOLONE TABLET 55 MITOXANTRONE INJECTABLE 101 PENTOSTATIN INJECTABLE 54 CYCLOSPORINE INJECTABLE 97 TRETINOIN SOLUTION 53 CYTARABINE INJECTABLE 96 FLUOXETINE CAPSULE 53 ETOPOSIDE CAPSULE 94 FOLIC ACID INJECTABLE 53 NAPROXEN SUSPENSION 92 ACYCLOVIR SUSPENSION 53 IBUPROFEN CAPSULE 92 CLADRIBINE INJECTABLE 52 DEXAMETHASONE TABLET 88 HYDROXYUREA CAPSULE 51 ERYTHROMYCIN SOLUTION 80 BENZYL BENZOATE EMULSION 50 CYCLOSPORINE CAPSULE 79 ... ... ...

Examples of Table 12 in a sentence

  • Subscription Services are provided for Software only when used for its supported purpose (“Use Case”) in accordance with the terms of this Exhibit and Table 1.2 below.

  • Table 12 provides the same type of information for private industry workers.

  • Cancer Causes in Developed and Developing Countries (2010): Percentage Breakdown by Risk Factors – Diet or Nutrition, Infections, Tobacco, and Other Factors (includes corresponding Graph/Chart) Types of Cancers Prostate CancerSelect FDA-Approved Prostate Cancer DrugsSelect Prostate Cancer Agents in Mid- & Late-Stage Clinical Development Table 12.

  • Tests of the fine aggregate shall not exceed the limits for standard requirements prescribed in CSA A23.1, Table 12.

  • Tests of the coarse aggregate shall not exceed the limits for standard for requirements prescribed in CSA A23.1, Table 12, for concrete exposed to freezing and thawing.

  • Subscription Services are provided for Software only when used for its supported purpose (“Use Case”) in accordance with the terms of this Exhibit 1.E and Table 1.2 below.

  • The coarse aggregate shall satisfy the Standard Requirements specified in CSA A23.1, Table 12, “Concrete Exposed to Freezing and Thawing”.

  • The value range of should be 0~23 for dedicated PUCCH resources, the candidate values of for common PUCCH resource in Table 1-1 and the candidate values of in Table 1-2 to Table 1-5 should all multiply by 2.

  • Please fill in table 1.2Add Row Table 1.2 Aquatic genetic resources of wild relatives of farmed aquatic species in your country.

  • I have adopted the Charbonneau r outcome as the final results for HD 149026 (Table 12), but have increased the error estimates to re- flect the difference between the r and (b y)/2 solutions.


More Definitions of Table 12

Table 12. Means across the evaluators of the inter-segment angles between parent and child reference systems. Hindfoot/tibia (HF/TB), forefoot/hindfoot (FF/HF), toes/forefoot (TO/FF). Subject 1 Subject 2 Subject 3 mean (deg) mean (deg) mean (deg) Joint x (sd) y (sd) z (sd) x (sd) y (sd) z (sd) x (sd) y (sd) z (sd) HF/TB -8.41 (1.36) -18.72 (3.45) -24.12 (1.64) 13.93 (1.36) 4.50 (5.34) -9.69 (0.26) -8.15 (3.02) -5.40 (3.32) -16.37 (1.72) FF/HF -3.34 (3.55) 1.19 (3.80) -6.64 (2.66) 5.67 (1.14) -10.11 (3.63) -4.82 (0.90) -6.73 (2.32) 10.37 (1.16) -5.85 (5.00) TO/FF 0.00 0.00 9.58 (2.40) 0.00 0.00 -7.77 (3.37) 0.00 0.00 -2.84 (7.04) Some operator-dependent variability in the orientation of adjacent segments was found, even if this aspect was less dramatic than the others investigated within the study. The issue of the repeatability of joint axes definition could be solved by introducing semi-automatic fitting routines. These have now been implemented and will be described in the section dedicated to the updated modelling pipeline.
Table 12. Anticipated impacts of contextualised pathways in Kinzigtal Care recipient (CR) Positive impacts / benefits • Improvement of self care capacity. • Patient empowerment. • Improved satisfaction with service delivery. • Perception of service-specific impacts such as safety and security, improved physical status, improved communication with care providers, reduced social isolation, etc. Negative impacts / costs • Feeling of loss of privacy, bureaucratic initial procedures with confirmation for data protection. • Time taken to use the service. • Possible co-payment after the pilot. Informal carer (I/FC) Positive impacts / benefits • Better information level of the CR. • Information on demand, independent of time. • Feeling of more security about the status of the CR. • Improved satisfaction with service delivery. • Reduced carer burden. Negative impacts / costs • Assumption of new tasks, for example appointment at GP, shopping. • Excessive demand. • Time taken for the provision of support. Social care provider (SCP) Positive impacts / benefits • Higher information level. • Transparency about completed / not completed tasks in the care pathway. • More responsibility for documentation. • Legal security. • Easier and faster way of communication with health care providers, for example recalls at the GP. • Reducing time per case. Negative impacts / costs • Data overflow if irrelevant information comes into the common electronic patient record, new way of using the documentation software. • Time taken to train staff. • Time taken to provide service. • Technical malfunction disables care pathway. Health care provider (HCP) Positive impacts / benefits • Higher information level, easier way of communication with social care providers, time saving during the visit calls in the residence home. • Reduced visits at the patient's home. Negative impacts / costs • Data overflow if irrelevant information comes into the common electronic patient record, new way of using the documentation software. • Time taken to train staff. • Time taken to provide service. • Reduced income because loss of home visits. Third-sector care provider (TSCP) Positive impacts / benefits • Possibility to be more involved into the social care process. Negative impacts / costs • Data overflow if irrelevant information comes into the common electronic patient record, new way of using the documentation software. • Time taken to train staff. • Time taken to provide service. • Reduced income because loss of ...
Table 12. Frequency of Slut as Reference by Relationship Frequency “close” relationships at 2.0, while the rest of use and relationships measure at 1.0. The mode for each relationship by use is 1.0. Further, the breakdown of frequency by relationship, in Table 13, was overwhelming reported as “never”. However, use was still highest among “close friends”, at ‘hardly ever’, followed by ‘once a week/day’. Scale Report Breakdown of Slut by Relationship (Reference) 70 60 50 40 30 20 10 0 64 67 67 49 54 50 32 16 9 11 5 4 2 521 632 753 0 0 0 0 2 1
Table 12 means the table entitled “Aircraft Information Table 12 for the Substitute 767 Aircraft to the Purchase Agreement”.
Table 12. Taxable income: comparison of weighted and unweighted indicators Taxable income (unweighted) Taxable income (weighted* ) mean 19878 21561 25% 12138 13369 50% 17826 19774 75% 25233 27295 * weights are calculated following the indirect sampling methodology (see § 4.3.1)
Table 12. Correlation between the Tonometers in the high IOP Group Tonometer Xxxxxxx’x Correlation Coefficient (r) GAT vs Tonopen 0.84 GAT vs NCT 0.763 GAT vs DCT 0.725 Table 13: Mean Difference in IOP between GAT and other Tonometers in the Normal Group Mean Difference in IOP p value GAT-TONOPEN 2.7 0.00 GAT-NCT 0.77 0.04 GAT-DCT -1.61 0.00 We looked at the difference in IOP recorded by GAT and each of the other 3 tonometers for each patient in the normal IOP group. In this group the least difference was between GAT and NCT, though statistically significant. Table 13 shows the mean difference and p value. In normotensives it was found that the mean of the difference in IOP was least between GAT and NCT,ie 0.77. DCT tends to show slightly higher IOP than GAT. Between Tonopen and GAT there is a difference of 2.7, and Tonopen underestimated IOP. Table 13: Mean Difference in IOP between GAT and other Tonometers in the high IOP Group Mean difference in IOP P value GAT-TONOPEN 5.29 0.00 GAT-NCT 4.23 0.00 GAT-DCT 2.4 0.00 In this group, (Table 13) there is statistically significant difference between GAT and all three tonometers. The results of our study show that all the other istruments tend to underestimate IOP in patients with IOP more than 24 mm Hg. Among the three instruments, Tonopen showed highest difference and DCT showed the lowest difference.

Related to Table 12

  • Table 4 Ending this Addendum when the Approved Addendum Changes Ending this Addendum when the Approved Addendum changes Which Parties may end this Addendum as set out in Section 19: Importer Exporter neither Party

  • Table 1 means Table 1 of the Reporting ITS.

  • Table 2 means Table 2 of the Reporting ITS.

  • Table E academic outcomes at receiving institution Component code (if any) Component title (as indicated in the course catalogue) at the receiving institution Was the component successfully completed by the student? [Yes/No] Number of ECTS credits Receiving institution grade Total: [Signature of responsible person in receiving institution and date]

  • Table means the table at the end of this §4a.

  • Matrix (1 2 8 9) means a substantially continuous phase that fills the space between particles, whiskers or fibres.

  • Table A means Table A in the First Schedule;

  • Basic Prices means the prices for the specified materials prevailing on the date 28 days prior to the latest date for submission of Tenders.

  • Composite mortality tables means mortality tables with rates of mortality that do not distinguish between smokers and nonsmokers.

  • Level IV shall exist at any time the Total Leverage Ratio is greater than or equal to 4.00:1.0 but less than 4.50:1.0.

  • Unit Price Table means the table of prices per unit set out in the Contract;

  • Polystyrene foam means blown polystyrene and expanded and

  • engine type means a category of engines which do not differ in essential engine characteristics.

  • Expanded polystyrene means blown polystyrene and expanded

  • Emission Summary Table means the table prepared in accordance with O. Reg. 419/05 and the Procedure Document listing the appropriate Point of Impingement concentrations of each Compound of Concern from the Facility and providing comparison to the corresponding Ministry Point of Impingement Limit or Maximum Concentration Level Assessment.

  • MARPOL 73/78 means the International Convention for the Prevention of Pollution from Ships, 1973, as amended by the Protocol of 1978 relating thereto and by any other amendment in force thereafter;

  • Lead Limits means the maximum concentrations of lead and lead compounds (“Lead”) by weight specified in Section 3.2.

  • Table of Contents is deleted in its entirety and replaced with the attached “Table of Contents” (identified by “SA-11”).

  • Maintenance Margin means the minimum amount of money required in your Trading Account as specified on the Trading Platform in order to keep a Transaction open on the Trading Platform.

  • frequency ride through as used herein shall mean the ability of a Small Generating Facility to stay connected to and synchronized with the system or equipment of the Transmission Owner and any Affected Systems during system disturbances within a range of under-frequency and over- frequency conditions, in accordance with Good Utility Practice and consistent with any standards and guidelines that are applied to other generating facilities in the Balancing Authority Area on a comparable basis. The term “voltage ride through” as used herein shall mean the ability of a Small Generating Facility to stay connected to and synchronized with the system or equipment of the Transmission Owner and any Affected Systems during system disturbances within a range of under-voltage and over-voltage conditions, in accordance with Good Utility Practice and consistent with any standards and guidelines that are applied to other generating facilities in the Balancing Authority Area on a comparable basis.

  • Tomogram means the depiction of the x-ray attenuation properties of a section through the body.

  • Level I means a component of the federal PASRR requirement. Level I refers to the identification of individuals who are potential nursing facility admissions who have indicators of mental illness or developmental disabilities (42 CFR 483.128(a)).

  • Level II means a component of the federal PASRR requirement. Level II refers to the evaluation and determination of whether nursing facility services and specialized services are needed for individuals with mental illness or developmental disability who are potential nursing facility admissions, regardless of the source of payment for the nursing facility service (42 CFR 483.128(a)). Level II evaluations include assessment of the individual’s physical, mental, and functional status (42 CFR 483.132).

  • Standard reference compendia means the American Medical Association Drug Evaluations, the

  • Specific goals means specific goals as contemplated in section 2(1)(d) of the PPPFA which may include contracting with persons, or group of persons, historically disadvantaged by unfair discrimination on the basis of race, gender and disability including the implementation of programmes of the Reconstruction and Development Programme as published in Government Gazette No. 16085 dated 23 November 1994.

  • Snow tyre means a tyre whose tread pattern, tread compound or structure is primarily designed to achieve in snow conditions a performance better than that of a normal tyre with regard to its ability to initiate or maintain vehicle motion."